Tag Archives: Ebola

FDA Approves Inmazeb (atoltivimab, maftivimab and odesivimab-ebgn) Antibody Cocktail for Ebola (Zaire Ebolavirus)

TARRYTOWN, N.Y., Oct. 14, 2020 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced today that the U.S. Food and Drug Administration (FDA) approved Inmazeb (atoltivimab, maftivimab and odesivimab-ebgn) for the treatment of infection caused by Zaire ebolavirus in adult and pediatric patients, including newborns of mothers who have tested positive for the infection. “We are… Read More »

Ebola drug gives new hope to patients with coronavirus, says Dr Miriam Stoppard

Mid-March I wrote an article on possible drug treatments for Covid-19. Some of them were already available and being used to treat other ­conditions, but there was a move afoot among scientists to adapt them to overcome Covid. Among them was a promising ­candidate, remdesivir, which had achieved some success against Ebola and two coronaviruses.… Read More »

In Congo, a New Plan to Fight Ebola Follows a Government Power Struggle

Faced with a lethal Ebola outbreak threatening eastern Africa, public health officials are conceding that their battle plan is failing and have proposed a comprehensive new strategy for containing the virus. It envisions reframing the epidemic as a regional humanitarian crisis, not simply a health emergency. That may include more troops or police to quell… Read More »